ClearPoint Neuro (CLPT) Retained Earnings (2011 - 2026)
ClearPoint Neuro (CLPT) reported Retained Earnings of -$226.5 million for Q1 2026, down 14.74% on a YoY basis from -$265.7 million in Q1 2025, and down 4.42% sequentially from -$216.9 million in Q4 2025.
ClearPoint Neuro (CLPT) Retained Earnings (2011 - 2026) Analysis & Trends
ClearPoint Neuro (CLPT) has 16 years of Retained Earnings data on file, last reported at -$226.5 million in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings fell 14.74% year-over-year to -$226.5 million; the trailing twelve-month figure through Mar 2026 stood at -$226.5 million (down 14.74% YoY), and the FY2025 full-year result was -$216.9 million, down 13.35% from the prior year.
- Retained Earnings slipped to -$226.5 million in Q1 2026, from -$216.9 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of -$137.9 million in Q1 2022 to a low of -$226.5 million in Q1 2026.
- A 5-year average of -$177.9 million and a median of -$176.6 million in 2024 frame the typical range for Retained Earnings.
- Across the five-year window, Retained Earnings decreased 14.95% in 2023 and dropped 10.84% in 2024, its largest moves.
- Tracing CLPT's Retained Earnings over 5 years: stood at -$150.4 million in 2022, then retreated by 14.69% to -$172.5 million in 2023, then retreated by 10.97% to -$191.4 million in 2024, then declined by 13.35% to -$216.9 million in 2025, then declined by 4.42% to -$226.5 million in 2026.
- Business Quant data shows CLPT's Retained Earnings at -$226.5 million in Q1 2026, -$216.9 million in Q4 2025, and -$209.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -6.31 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -583.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -4.10 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 6.91 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 14.62 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.63 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -1.40 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 5.32 Bn |
| 10 | ClearPoint Neuro | 434.51 Mn | 398.91 Mn | 7.76 Mn | -226.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -226.50 Mn |
| Dec 31, 2025 | -216.91 Mn |
| Sep 30, 2025 | -209.12 Mn |
| Jun 30, 2025 | -203.20 Mn |
| Mar 31, 2025 | -197.40 Mn |
| Dec 31, 2024 | -191.37 Mn |
| Sep 30, 2024 | -185.98 Mn |
| Jun 30, 2024 | -181.01 Mn |
| Mar 31, 2024 | -176.60 Mn |
| Dec 31, 2023 | -172.46 Mn |
| Sep 30, 2023 | -167.80 Mn |
| Jun 30, 2023 | -163.03 Mn |
| Mar 31, 2023 | -156.00 Mn |
| Dec 31, 2022 | -150.37 Mn |
| Sep 30, 2022 | -145.98 Mn |
| Jun 30, 2022 | -142.19 Mn |
| Mar 31, 2022 | -137.89 Mn |
| Dec 31, 2021 | -133.93 Mn |
| Sep 30, 2021 | -130.00 Mn |
| Jun 30, 2021 | -125.80 Mn |